The Atlanta Journal-Constitution (1/6, Clanton) reports Aurobindo Pharma USA, based in New Jersey, “has voluntarily recalled a lot of its depression drug mirtazapine because the label could have the wrong strength of the medication, the Food and Drug Administration announced recently.” According to the agency, “the bottles labeled as 7.5 mg pills might contain 15 mg tablets.” (SOURCE: APA Headlines)